This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Taheebo Japan Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations of Katsumi Nishimura
Introduction
Katsumi Nishimura is a notable inventor based in Kochi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer compounds. His work focuses on creating effective and efficient methods for synthesizing important chemical intermediates.
Latest Patents
Katsumi Nishimura holds a patent for an anticancer compound, which includes a method for preparing a racemate or an optically-active 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4,9-dione. This compound is produced in high yields and serves as an intermediate for preparing NFD, an anticancer agent. The synthesis process involves using comparatively inexpensive 5-hydroxynaphthalene-1,4-dione, also known as juglone, as a starting material. He has 1 patent to his name.
Career Highlights
Katsumi Nishimura is associated with Taheebo Japan Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has the potential to impact cancer treatment significantly, providing new avenues for research and development.
Collaborations
Katsumi has collaborated with Harukuni Tokuda, contributing to the advancement of their shared research interests.
Conclusion
Katsumi Nishimura's contributions to the field of medicinal chemistry highlight the importance of innovation in developing effective treatments for cancer. His work exemplifies the potential of scientific research to improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile